Table 3.
Before treatment mean (SD) | 95% CI | Six month follow up mean (SD) | 95% CI | P-valueb | ||
---|---|---|---|---|---|---|
Chemotherapy (N = 20) | VO2max (ml kg−1. min− 1) | 31 (7.1) | 27.6–34.3 | 28.7 (6.2) | 25.8–31.6 | .191 |
VE peak (L min− 1) | 84 (15.4) | 76.8–91.2 | 82.4 (19.4) | 73.3–91.5 | .296 | |
RER peak | 1.25 (0.1) | 1.22–1.29 | 1.22 (0.1) | 1.17–1.27 | .147 | |
RPE peak | 17.2 (1.2) | 16.6–17.8 | 17.8 (1.2) | 17.2–18.3 | .058 | |
HR peak (beats. min−1) | 173 (13) | 166.5–178.6 | 170 (11.1) | 164.3–174.6 | .054 | |
Radiotherapy (N = 18) | VO2max (ml kg−1. min− 1) | 29.4 (6.7) | 26.1–32.7 | 29.4 (7.9) | 25.5–33.3 | .794 |
VE peak (L min− 1) | 77.8 (18.7) | 68.5–87.1 | 73.5 (28.2) | 59.4–87.5 | .845 | |
RER peak | 1.20 (0.1) | 1.15–1.25 | 1.17 (0.1) | 1.12–1.23 | .140 | |
RPE peak | 16.6 (1.3) | 15.9–17.2 | 17.2 (1.5) | 16.4–17.9 | .031* | |
HR peak (beats. min−1) | 169 (20.4) | 158.6–178.9 | 165 (16.4) | 156.7–173 | .138 | |
Endocrine therapy (N = 17) | VO2max (ml kg− 1. min− 1) | 32 (6.8) | 28.5–35.5 | 33.1 (9.2) | 28.4–37.8 | .162 |
VE peak (L min− 1) | 86.6 (18.6) | 77.1–96.2 | 83.7 (17.2) | 74.8–92.5 | .113 | |
RER peak | 1.23 (0.1) | 1.16–1.30 | 1.19 (0.1) | 1.13–1.24 | .162 | |
RPE peak | 17.4 (1.2) | 16.8–18 | 17.2 (1.7) | 16.3–18.1 | .558 | |
HR peak (beats. min−1) | 166 (17.8) | 156.9–175.2 | 166 (19.7) | 156.2–176.4 | .816 |
a Abbreviations: VO2max, highest recorded oxygen uptake during exercise test; VE peak, highest recorded ventilation; RER peak, highest recorded respiratory exchange ratio; RPE peak, highest reported perceived exertion; HR peak, highest recorded heart rate; MVPA, Moderate and vigorous physical activity
b P-values for any differences between groups